MS
BIIB icon

Mizuho Securities’s Biogen BIIB Stock Holding History

Mizuho Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,840
Closed -$1.02M – 96
2022
Q3 		$1.02M Buy
+3,840
New +$816K 0.35% 15
2021
Q4 		– Sell
-30
Closed -$8K – 201
2021
Q3 		$8K Buy
+30
New +$9.83K ﹤0.01% 100
2021
Q2 		– Sell
-500
Closed -$140K – 206
2021
Q1 		$140K Sell
500
-600
-55% -$162K 0.03% 45
2020
Q4 		$269K Buy
1,100
+400
+57% +$103K 0.05% 30
2020
Q3 		$199K Sell
700
-2,100
-75% -$586K 0.04% 46
2020
Q2 		$886K Buy
2,800
+466
+20% +$140K 0.25% 17
2020
Q1 		$738K Sell
2,334
-897
-28% -$272K 1.32% 19
2019
Q4 		$959K Buy
+3,231
New +$896K 0.51% 32
2019
Q3 		– Sell
-200
Closed -$47K – 135
2019
Q2 		$47K Buy
+200
New +$46.2K 0.06% 109
2019
Q1 		– Sell
-100
Closed -$30K – 121
2018
Q4 		$30K Buy
+100
New +$31.9K ﹤0.01% 93

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mizuho Securities's BIIB Position: Q4 2022 in Review

Mizuho Securities sold out of Biogen (BIIB) in Q4 2022, closing a stake of 3,840 shares — an estimated $1.02M sold.

Mizuho Securities first reported a position in BIIB in Q4 2018 and held it in 10 quarters. The position peaked at $1.02M in Q3 2022. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Mizuho Securities reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Mizuho Securities sold 3,840 Biogen shares in Q4 2022, an estimated $1.02M.
  • Mizuho Securities first reported a position in Biogen in Q4 2018 and held it in 10 quarters.
  • Mizuho Securities's Biogen position peaked at $1.02M in Q3 2022.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Mizuho Securities's 13F filing for Q4 2022, filed 7 Feb 2023.